<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04877561</url>
  </required_header>
  <id_info>
    <org_study_id>ZUAS HDQ</org_study_id>
    <nct_id>NCT04877561</nct_id>
  </id_info>
  <brief_title>Test-Retest Reliability of the German Version of the Headache Disability Questionnaire (HDQ).</brief_title>
  <official_title>Translation, Trans-cultural Adaptations and Test-retest Reliability of the Headache Disability Questionnaire (HDQ)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zurich University of Applied Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zurich University of Applied Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      a translated and cultural adapted version of the HDQ will be tested on two occasions with&#xD;
      headache patients who are currently in physiotherapeutic treatment due to their headache&#xD;
      condition&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The test-retest reliability of the German version of the HDQ will be tested to assess the&#xD;
      reproducibility of the test results with a stable condition of the participants over a short&#xD;
      period of time. For this purpose, it is planned to administer the questionnaire twice in row&#xD;
      at an interval of 48 - 72 hours to headache patients in outpatient physiotherapy. The chosen&#xD;
      setting limits the sample to a common intervention measure (physiotherapy), so that primary&#xD;
      and secondary headache types can be included and the requirements of the original study can&#xD;
      be maintained. In the period between the two tests, subjects should not receive&#xD;
      physiotherapy, because it can often have different effects on headache. This can lead to&#xD;
      uneven changes in the sample and affect the variance of the test results. However, subjects&#xD;
      are allowed to take their usual medications. To avoid recall bias, an online survey tool&#xD;
      (RedCAP) to conduct the questionnaire will be used. It is designed so that, only one question&#xD;
      appears per slide, no overview of responses is allowed and the questions are displayed in a&#xD;
      different order at the second testing. The lower prevalence of headaches after the age of 65&#xD;
      years is taken into account in the inclusion criteria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Headache</measure>
    <time_frame>June 21 to July 22</time_frame>
    <description>Nine item headache disability questionnaire (HDQ)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Headache disorder</measure>
    <time_frame>June 21 to July 22</time_frame>
    <description>Migraine, Tension-type headache, other</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Headache Disorders</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects suffering from a headache condition and are due to that in physiotherapeutic care&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  within physiotherapeutic care due to headache for no longer than 3 months&#xD;
&#xD;
          -  headache conditions for at least one month and at least once /month&#xD;
&#xD;
          -  live in Switzerland&#xD;
&#xD;
          -  give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  not in physiotherapeutic care&#xD;
&#xD;
          -  in physiotherapeutic care due to other conditions not associated with headache&#xD;
&#xD;
          -  younger than 18 and older than 65 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus J Ernst, Master</last_name>
    <role>Study Director</role>
    <affiliation>Zurich University of Applied Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Markus J Ernst, Master</last_name>
    <phone>+41 58 9346448</phone>
    <email>markus.ernst@zhaw.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dimo Ivanov, BSc</last_name>
    <email>ivanodim@students.zhaw.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zurich University of Applied Sciences</name>
      <address>
        <city>Winterthur</city>
        <state>Zurich</state>
        <zip>8400</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Niere K, Quin A. Development of a headache-specific disability questionnaire for patients attending physiotherapy. Man Ther. 2009 Feb;14(1):45-51. Epub 2007 Nov 7.</citation>
    <PMID>17997346</PMID>
  </reference>
  <reference>
    <citation>Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010 Aug;11(4):289-99. doi: 10.1007/s10194-010-0217-0. Epub 2010 May 16. Review.</citation>
    <PMID>20473702</PMID>
  </reference>
  <reference>
    <citation>Luedtke K, Basener A, Bedei S, Castien R, Chaibi A, Falla D, Fernández-de-Las-Peñas C, Gustafsson M, Hall T, Jull G, Kropp P, Madsen BK, Schaefer B, Seng E, Steen C, Tuchin P, von Piekartz H, Wollesen B. Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study. BMJ Open. 2020 Feb 12;10(2):e029855. doi: 10.1136/bmjopen-2019-029855.</citation>
    <PMID>32051295</PMID>
  </reference>
  <reference>
    <citation>Benz T, Lehmann S, Gantenbein AR, Sandor PS, Stewart WF, Elfering A, Aeschlimann AG, Angst F. Translation, cross-cultural adaptation and reliability of the German version of the migraine disability assessment (MIDAS) questionnaire. Health Qual Life Outcomes. 2018 Mar 9;16(1):42. doi: 10.1186/s12955-018-0871-5.</citation>
    <PMID>29523138</PMID>
  </reference>
  <reference>
    <citation>Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF. A comparison of two time intervals for test-retest reliability of health status instruments. J Clin Epidemiol. 2003 Aug;56(8):730-5.</citation>
    <PMID>12954464</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2021</study_first_posted>
  <last_update_submitted>May 7, 2021</last_update_submitted>
  <last_update_submitted_qc>May 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zurich University of Applied Sciences</investigator_affiliation>
    <investigator_full_name>Markus J. Ernst</investigator_full_name>
    <investigator_title>Research fellow, MSc,</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no intention to share the IPD</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

